Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-02-03 @ 6:02 AM
Study NCT ID:
NCT02923934
Status:
COMPLETED
Last Update Posted:
2024-07-24
First Post:
2016-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Sponsor:
Olivia Newton-John Cancer Research Institute
Organization: